Childhood moyamoya disease and moyamoya syndrome: A pictorial review

Pediatric Neurology

Volumn 44, Issue 6, 2011, Pages 401-413

  Currie, Stuart ^a   Raghavan, Ashok ^b   Batty, Ruth ^b   Connolly, Daniel J A ^b   Griffiths, Paul D ^c  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ALAGILLE SYNDROME; ANTIPHOSPHOLIPID SYNDROME; ARTERY OCCLUSION; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONVENTIONAL ANGIOGRAPHY; DOWN SYNDROME; ENCEPHALOMENINGOCELE; FANCONI ANEMIA; GLYCOGEN STORAGE DISEASE; HEAD AND NECK INFECTION; HEMOPHILIA; HEREDITARY SPHEROCYTOSIS; HUMAN; HYPOMELANOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MOYAMOYA DISEASE; MULTICENTER STUDY; NEUROFIBROMATOSIS; NEURORADIOLOGY; NOONAN SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION; REVIEW; ROBINOW SYNDROME; SICKLE CELL ANEMIA; SJOEGREN SYNDROME; TUBERCULOSIS; TUBERCULOUS MENINGITIS; WILLIAMS BEUREN SYNDROME;

CAROTID STENOSIS; CEREBRAL ANGIOGRAPHY; CHILD; CHRONIC DISEASE; DIAGNOSTIC IMAGING; HUMANS; MOYAMOYA DISEASE; STROKE; SYNDROME;

EID: 79955804380     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2011.02.007     Document Type: Review

References (123)

1. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ("moyamoya" disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997;99(Suppl. 2):S238-40.
2. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease: Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288-99.
3. Wakai K, Tamakoshi A, Ikezaki K, et al. Epidemiological features of moyamoya disease in Japan: Findings from a nationwide survey. Clin Neurol Neurosurg 1997;99(Suppl. 2):S1-5.
4. Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 2008;79:900-4.
5. Suzuki J, Kodama N. Moyamoya disease - A review. Stroke 1983;14:104-9.
6. Caldarelli M, Di Rocco C, Gaglini P. Surgical treatment of moyamoya disease in pediatric age. J Neurosurg Sci 2001;45:83-91. (Pubitemid 32979941)
7. Uchino K, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology 2005;65:956-8. (Pubitemid 41362154)
8. Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG. Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 1997;99(Suppl. 2):S58-60.
9. Smith E, Scott R. Moyamoya: Epidemiology, presenation, and diagnosis. Neurosurg Clin North Am 2010;21:543-51.
10. Soriano SG, Sethna NF, Scott RM. Anesthetic management of children with moyamoya syndrome. Anesth Analg 1993;77:1066-70. (Pubitemid 23319812)
11. Nagaraja D, Verma A, Taly AB, Kumar MV, Jayakumar PN. Cerebrovascular disease in children. Acta Neurol Scand 1994;90:251-5. (Pubitemid 24321498)
12. Yonekawa Y, Taub E. Moyamoya disease: Status. Neurologist 1999;5:13-23.
13. Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H. Cerebral revascularization using omental transplantation for childhood moyamoya disease. J Neurosurg 1993;79:192-6. (Pubitemid 23215834)
14. Miyamoto S, Kikuchi H, Karasawa J, Nagata I, Ihara I, Yamagata S. Study of the posterior circulation in moyamoya disease. Part 2: Visual disturbances and surgical treatment. J Neurosurg 1986;65:454-60. (Pubitemid 16000689)
15. Zheng W, Wanibuchi M, Onda T, et al. A case of moyamoya disease presenting with chorea. Childs Nerv Syst 2006;22:274-8.
16. Bowen M, Marks MP, Steinberg GK. Neuropsychological recovery from childhood moyamoya disease. Brain Dev 1998;20:119-23. (Pubitemid 28130240)
17. Kuroda S, Houkin K. Moyamoya disease: Current concepts and future perspectives. Lancet Neurol 2008;7:1056-66.
18. Handa J, Nakano Y, Okuno T, Komuro H, Hojyo H, Handa H. Computerized tomography in moyamoya syndrome. Surg Neurol 1977;7:315-9. (Pubitemid 8085795)
19. Meyers P, Halbach V, Barkovich A. Anomalies of cerebral vasculature: Diagnostic and endovascular considerations. In: Barkovich A, editor. Pediatric neuroimaging. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2000:806.
20. Gaa J, Weidauer S. Unusual differential diagnosis of leptomeningeal enhancement: Moyamoya disease. J Neurol Neurosurg Psychiatry 2004;75:1170. (Pubitemid 39005778)
21. Komiyama M, Nakajima H, Nishikawa M, Yasui T, Kitano S, Sakamoto H. Leptomeningeal contrast enhancement in moyamoya: Its potential role in postoperative assessment of circulation through the bypass. Neuroradiology 2001;43:17-23. (Pubitemid 32123962)
22. Maeda M, Tsuchida C. "Ivy sign" on fluid-attenuated inversion-recovery images in childhood moyamoya disease. AJNR 1999;20:1836-8.
23. Ohta T, Tanaka H, Kuroiwa T. Diffuse leptomeningeal enhancement, "ivy sign," in magnetic resonance images of moyamoya disease in childhood: Case report. Neurosurgery 1995;37:1009-12.
24. Maeda M, Yagishita A, Yamamoto T, Sakuma H, Takeda K. Abnormal hyperintensity within the subarachnoid space evaluated by fluid-attenuated inversion-recovery MR imaging: A spectrum of central nervous system diseases. Eur Radiol 2003;13(Suppl. 4):L192-201.
25. Tosaka M, Sato N, Fujimaki H, et al. Diffuse pachymeningeal hyperintensity and subdural effusion/hematoma detected by fluid-attenuated inversion recovery MR imaging in patients with spontaneous intracranial hypotension. AJNR 2008;29:1164-70. (Pubitemid 351954888)
26. Cho HJ, Jung YH, Kim YD, Nam HS, Kim DS, Heo JH. The different infarct patterns between adulthood-onset and childhood-onset moyamoya disease. J Neurol Neurosurg Psychiatry 2011;82:38-40.
27. Adams RJ, Brambilla DJ, Granger S, et al. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP Study. Blood 2004;103:3689-94. (Pubitemid 38596283)
28. Bacigaluppi S, Dehdashti A, Agid R, Krings T, Tymianski M, Mikulis D. The contribution of imaging in diagnosis, preoperative assessment, and follow-up of moyamoya disease. Neurosurg Focus 2009;26:E3a.
29. Houkin K, Tanaka N, Takahashi A, Kamiyama H, Abe H, Kajii N. Familial occurrence of moyamoya disease: Magnetic resonance angiography as a screening test for high-risk subjects. Childs Nervous Syst 1994;10:421-5. (Pubitemid 24293904)
30. Houkin K, Aoki T, Takahashi A, Abe H. Diagnosis of moyamoya disease with magnetic resonance angiography. Stroke 1994;25:2159-64. (Pubitemid 24338369)
31. Scott RM, Smith ER. Introduction: Moyamoya disease. Neurosurg Focus 2009;26:E1.
32. Houkin K, Nakayama N, Kuroda S, Nonaka T, Shonai T, Yoshimoto T. Novel magnetic resonance angiography stage grading for moyamoya disease. Cerebrovasc Dis 2005;20:347-54. (Pubitemid 41551985)
33. Kawaguchi S, Sakaki T, Morimoto T, Kakizaki T, Kamada K. Characteristics of intracranial aneurysms associated with moyamoya disease: A review of 111 cases. Acta Neurochir (Wien) 1996;138:1287-94. (Pubitemid 26390428)
34. Kikuta K. Experiences using 3-Tesla magnetic resonance imaging in the treatment of Moyamoya disease. Acta Neurochir (Wien) 2008;103(Suppl.):123-6.
35. Reis CVC, Safavi-Abbasi S, Zabramski JM, Gusmao SNS, Spetzler RF, Preul MC. The history of neurosurgical procedures for moyamoya disease. Neurosurg Focus 2006;20:E7.
36. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004;100(Suppl. 2):142-9. (Pubitemid 38141339)
37. Ishikawa T, Kamiyama H, Kuroda S, Yasuda H, Nakayama N, Takizawa K. Simultaneous superficial temporal artery to middle cerebral or anterior cerebral artery bypass with pan-synangiosis for Moyamoya disease covering both anterior and middle cerebral artery territories. Neurol Med Chir (Tokyo) 2006;46:462-8.
38. Cashen TA, Carr JC, Shin W, et al. Intracranial time-resolved contrast-enhanced MR angiography at 3T. AJNR 2006;27:822-9. (Pubitemid 44897730)
39. Kashiwagi S, Yamashita T, Katoh S, et al. Regression of moyamoya vessels and hemodynamic changes after successful revascularization in childhood moyamoya disease. Acta Neurol Scand 1996;166(Suppl.):85-8. (Pubitemid 26180523)
40. Houkin K, Nakayama N, Kuroda S, Ishikawa T, Nonaka T. How does angiogenesis develop in pediatric moyamoya disease after surgery? A prospective study with MR angiography. Childs Nerv Syst 2004;20:734-41. (Pubitemid 39378343)
41. Roach S, Golomb M, Adams R, et al. Management of stroke in infants and children: A scientific statement from a special writing group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008;39:2644-91.
42. Roach ES. Etiology of stroke in children. Semin Pediatr Neurol 2000;7:244-60.
43. Kirkham F, Debaun M. Stroke in children with sickle cell disease. Curr Treat Options Neurol 2004;6:357-75. (Pubitemid 39214220)
44. Rosser T, Vezina G, Packer R. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology 2005;64:553-5. (Pubitemid 40189883)
45. Jea A, Smith ER, Robertson R, Scott RM. Moyamoya syndrome associated with Down syndrome: Outcome after surgical revascularization. Pediatrics 2005;116:e694-701.
46. Yamada H, Deguchi K, Tanigawara T, et al. The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg 1997;99(Suppl. 2):S221-4.
47. Nanba R, Tada M, Kuroda S, Houkin K, Iwasaki Y. Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease. Childs Nerv Syst 2005;21:62-8.
48. Soriano SG, Cowan DB, Proctor MR, Scott RM. Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome. Neurosurgery 2002;50:544-9. (Pubitemid 36322837)
49. Masuda J, Ogata J, Yamaguchi T. Moyamoya disease. In: Mohr J, Choi D, Grotta J, Weir B, Wolf P, editors. Stroke: Pathophysiology, diagnosis and management. 4th ed. New York: Churchill Livingstone, 2004:603-18.
50. Ezura M, Yoshimoto T, Fujiwara S, Takahashi A, Shirane R, Mizoi K. Clinical and angiographic follow-up of childhood-onset moyamoya disease. Childs Nerv Syst 1995;11:591-4.
51. Imaizumi C, Imaizumi T, Osawa M, Fukuyama Y, Takeshita M. Serial intelligence test scores in pediatric moyamoya disease. Neuropediatrics 1999;30:294-9. (Pubitemid 30088320)
52. Moritake K, Handa H, Yonekawa Y, Taki W, Okuno T. Followup study on the relationship between age at onset of illness and outcome in patients with moyamoya disease [in Japanese]. No Shinkei Geka [Neurol Surg] 1986;14:957-63.
53. Kurokawa T, Tomita S, Ueda K, et al. Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatr Neurol 1985;1:274-7. (Pubitemid 17029754)
54. Handa H, Yonekawa Y. Analysis of the filing data bank of 1500 cases of spontaneous occlusion of the circle of Willis and follow-up study of 200 cases for more than 5 years. Stroke (Tokyo) 1985;7:477-80.
55. Imaizumi T, Hayashi K, Saito K, Osawa M, Fukuyama Y. Long-term outcomes of pediatric moyamoya disease monitored to adulthood. Pediatr Neurol 1998;18:321-5. (Pubitemid 28191525)
56. Vilela MD, Newell DW. Superficial temporal artery to middle cerebral artery bypass: Past, present, and future. Neurosurg Focus 2008;24:E2.
57. Golby AJ, Marks MP, Thompson RC, Steinberg GK. Direct and combined revascularization in pediatric moyamoya disease. Neurosurgery 1999;45:50-60. (Pubitemid 29318874)
58. Ishikawa T, Houkin K, Kamiyama H, Abe H. Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. Stroke 1997;28:1170-3. (Pubitemid 27248890)
59. Houkin K, Ishikawa T, Yoshimoto T, Abe H. Direct and indirect revascularization for moyamoya disease surgical techniques and perioperative complications. Clin Neurol Neurosurg 1997;99(Suppl. 2):S142-5.
60. Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H. Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg 1992;77:84-9.
61. Miyamoto S, Akiyama M, Nagata I, et al. Long-term outcome after STA-MCA anastomosis for moyamoya disease. Neurosurg Focus 1998;5:1-4.
62. Choi JU, Kim DS, Kim EY, Lee KC. Natural history of moyamoya disease: Comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neurosurg 1997;99(Suppl. 2):S11-8.
63. Ohaegbulam C, Magge S, Scott R. Moyamoya syndrome. In: McLone D, editor. Pediatric neurosurgery. Philadelphia: W.B. Saunders, 2001:1077-92.
64. Kelly M, Bell-Stephens T, Marks M, Do H, Steinberg G. Progression of unilateral moyamoya disease: A clinical series. Cerebovasc Disord 2006;22:109-15. (Pubitemid 44114451)
65. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y. Research Committee on Moyamoya Disease in Japan. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: Results of multicenter survey in Japan. Stroke 2007;38:1430-5.
66. Smith ER, Scott RM. Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus 2008;24:E17.
67. Kawano T, Fukui M, Hashimoto N, Yonekawa Y. Follow-up study of patients with "unilateral" moyamoya disease. Neurol Med Chir (Tokyo) 1994;34:744-7.
68. Ikezaki K, Matsushima T, Kuwabara Y, Suzuki S, Nomura T, Fukui M. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: A perioperative positron emission tomography study. J Neurosurg 1994;81:843-50. (Pubitemid 24373464)
69. Stockman J, Nigro M, Mishkin M, Oski F. Occlusion of large cerebral vessels in sickle cell anemia. N Engl J Med 1972;287:846-9.
70. Moritani T, Numaguchi Y, Lemer NB, et al. Sickle cell cerebrovascular disease: Usual and unusual findings on MR imaging and MR angiography. Clin Imag 2004;28:173-86. (Pubitemid 38670245)
71. Wang WC. The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Curr Opin Hematol 2007;14:191-7. (Pubitemid 46597602)
72. Fukuyama Y, Osawa M, Kanai N. Moyamoya disease (syndrome) and the Down syndrome. Brain Dev 1992;14:254-6.
73. Dai AI, Shaikh ZA, Cohen ME. Early-onset Moyamoya syndrome in a patient with Down syndrome: Case report and review of the literature. J Child Neurol 2000;15:696-9.
74. Mito T, Becker LE. Vascular dysplasia in Down syndrome: A possible relationship to moyamoya disease. Brain Dev 1992;14:248-51.
75. Mathew NT, Abraham J, Chandy J. Cerebral angiographic features in tuberculous meningitis. Neurology 1970;20:1015-23.
76. Barkovich A. Infection of the nervous system. In: Barkovich A, editor. Pedaitric neuroimaging. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2000:735.
77. Sharfstein SR, Ahmed S, Islam MQ, Najjar MI, Ratushny V. Case of moyamoya disease in a patient with advanced acquired immunodeficiency syndrome. J Stroke Cerebrovasc Dis 2007;16:268-72. (Pubitemid 350116602)
78. Lee M, Zaharchuk G, Guzman R, Achrol A, Stephens TB, Steinberg G. Quantitative hemodynamic studies in moyamoya disease: A review. Neurosurg Focus 2009;26:E5.
79. VoVan P, Sabouraud P, Mac G, Abely M, Bednarek N. Moyamoya disease associated with hereditary spherocytosis. Pediatr Neurol 2011;44:69-71.
80. Smith J. Understanding and treating moyamoya disease in children. Neurosurg Focus 2009;26:E4.
81. Schroeder T. Cerebrovascular reactivity to acetazolamide in carotid artery disease: Enhancement of side-to-side CBF asymmetry indicates critically reduced perfusion pressure. Neurol Res 1986;8:231-6. (Pubitemid 17224105)
82. Rim N, Kim H, Shin Y, Kim S. Which CT perfusion parameter best reflects cerebrovascular reserve? Correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in moyamoya patients. AJNR 2008;29:1658-63.
83. Vagala A, Leacha J, Fernandez-Ulloaa M, Zuccarellob M. The acetazolamide challenge: Techniques and applications in the evaluation of chronic cerebral ischemia. AJNR 2009;30:876-84.
84. Piepgras A, Schmiedek P, Leinsinger G, Haberl R, Kirsch C, Einhaupl K. A simple test to assess cerebrovascular reserve capacity using transcranial Doppler sonography and acetazolamide. Stroke 1990;21:1306-11. (Pubitemid 20301787)
85. 2 responsiveness measured by positron emission tomography. J Cereb Blood Flow Metab 1988;8:227-35.
86. Nariai T, Matsushima Y, Imae S, Tanaka Y, Ishii K, Senda M, Ohno K. Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: A positron emission tomography study. J Neurol Neurosurg Psychiatry 2005;76:663-9. (Pubitemid 40569676)
87. Nariai T, Senda M, Ishii K, Wakabayashi S, Yokota T, Toyama H. Posthyperventilatory steal response in chronic cerebral hemodynamic stress: A positron emission tomography study. Stroke 1998;29:1281-92. (Pubitemid 28300057)
88. So Y, Lee H, Kim S, et al. Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularisation. Stroke 2005;36:1485-9. (Pubitemid 40967517)
89. Laborde G, Harders A, Klimek L, Hardenack M. Correlation between clinical, angiographic and transcranial Doppler sonographic findings in patients with moyamoya disease. Neurol Res 1993;15:87-92. (Pubitemid 23131417)
90. Lee Y, Jung K, Roh J. Diagnosis of moyamoya disease with transcranial Doppler sonography: Correlation study with magnetic resonance angiography. J Neuroimag 2004;14:319-23. (Pubitemid 39331614)
91. Muttaqin Z, Ohba S, Arita K, et al. Cerebral circulation in moyamoya disease: A clinical study using transcranial Doppler sonography. Surg Neurol 1993;40:306-13. (Pubitemid 23289914)
92. Lee M, Zaharchuk G, Guzman R, Achrol A, Stephens TB, Steinberg G. Quantitative hemodynamic studies in moyamoya disease: A review. Neurosurg Focus 2009;26:E5.
93. Sakamoto S, Ohba S, Shibukawa M, Kiura Y, Arita K, Kurisu K. CT perfusion imaging for childhood moyamoya disease before and after surgical revascularization. Acta Neurochir (Wien) 2006;148:71-81.
94. Perren F, Horn P, Vajkoczy P, Schmiedek P, Meairs S. Power Doppler imaging in detection of surgically induced indirect neoangiogenesis in adult moyamoya disease. J Neurosurg 2005;103:869-72. (Pubitemid 43194581)
95. Calamante F, Ganesan V, Kirkham F, et al. MR perfusion imaging in moyamoya syndrome. Stroke 2001;32:2810-6.
96. Tanaka Y, Nariari T, Nagaoka T, et al. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging - Comparison with positron emission tomography. J Cereb Blood Flow Metab 2006;26:291-300. (Pubitemid 43151584)
97. Lee T. Functional CT: Physiological models. Trends Biotechnol 2002;20(Suppl.):S3-10.
98. Laslo A, Eastwood J, Pakkiri P, Chen F, Lee T. CT perfusion-derived mean transit time predicts early mortality and delayed vasospasm after experimental subarachnoid hemorrhage. AJNR 2008;29:79-85.
99. Togao O, Mihara F, Yoshiura T, et al. Cerebral hemodynamics in moyamoya disease: Correlation between perfusion-weighted MR imaging and cerebral angiography. AJNR 2006;27:391-7. (Pubitemid 44897849)
100. Mikulis D, Krolczyk G, Desal H, et al. Preoperative and postoperative mapping of cerebrovascular reactivity in moyamoya disease by using blood oxygen level-dependent magnetic resonance imaging. J Neurosurg 2005;103:347-55. (Pubitemid 43193913)
101. Oshima H, Katayama Y, Hirayama T. Intracerebral steal phenomenon associated with global hyperemia in moyamoya disease during revascularization surgery. J Neurosurg 2000;92:949-54. (Pubitemid 30346512)
102. 2. Magn Reson Med 2001;45:1011-3.
103. Morioka M, Hamada J, Kawano T, et al. Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke 2003;34:90-5. (Pubitemid 36070806)
104. Shimizu H, Shirane R, Fujiwara S, Takahashi A, Yoshimoto T. Proton magnetic resonance spectroscopy in children with moyamoya disease. Clin Neurol Neurosurg 1997;99(Suppl.):S64-7.
105. Goldstein EM, Singer HS. Moyamoya-like disease in Down's syndrome. Pediatr Neurosurg 1990;16:14-6.
106. Sobata E, Ohkuma H, Suzuki S. Cerebrovascular disorders associated with von Recklinghausen's neurofibromatosis: A case report. Neurosurgery 1988;22:544-9. (Pubitemid 18095960)
107. Goutieres F, Bourgeois M, Trioche P, Demelier J, Odievre M, Labrune P. Moyamoya disease in a child with glycogen storage disease type Ia. Neuropediatrics 1997;28:133-4. (Pubitemid 27283059)
108. Matsuki Y, Kawakami M, Ishizuka T, et al. SLE and Sjogren's syndrome associated with unilateral moyamoya vessels in cerebral arteries. Scand J Rheumatol 1997;26:392-4. (Pubitemid 27471228)
109. Zulch K, Dreesbach H, Eschbach O. Occlusion of the middle cerebral artery with the formation of an abnormal arterial collateral system-moyamoya type - 23 months later. Neuroradiology 1974;7:19-24.
110. Bitzer M, Topka H. Progressive cerebral occlusive disease after radiation therapy. Stroke 1995;26:131-6.
111. Holz A, Woldenberg R, Miller D, Kalina P, Black K, Lane E. Moyamoya disease in a patient with hereditary spherocytosis. Pediatr Radiol 1998;28:95-7. (Pubitemid 28077443)
112. Matsuda M, Enomoto T, Yanaka K, Nose T. Moyamoya disease associated with hemophilia A: Case report. Pediatr Neurosurg 2002;36:157-60. (Pubitemid 34264229)
113. Cohen N, Berant M, Simon J. Moyamoya and Fanconi's anemia. Pediatrics 1980;65:804-5. (Pubitemid 10110473)
114. Levine SR, Fagan SC, Pessin MS, et al. Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use. Neurology 1991;41:1893-901.
115. Gordon N, Isler W. Childhood moyamoya disease. Dev Med Child Neurol 1989;31:103-7. (Pubitemid 19065585)
116. Komiyama M, Yasui T, Sakamoto H, et al. Basal meningoencephalocele, anomaly of optic disc and panhypopituitarism in association with moyamoya disease. Pediatr Neurosurg 2000;33:100-4.
117. Kaplan P, Levinson M, Kaplan BS. Cerebral artery stenoses in Williams syndrome cause strokes in childhood. J Pediatr 1995;126:943-5.
118. Connor SEJ, Hewes D, Ball C, Jarosz JM. Alagille syndrome associated with angiographic moyamoya. Childs Nerv Syst 2002;18:186-90. (Pubitemid 36024333)
119. Korematsu K, Yoshioka S, Maruyama T, et al. Moyamoya disease associated with midaortic syndrome. Pediatr Neurosurg 2007;43:54-9. (Pubitemid 46018603)
120. Booth F, Yanofsky R, Ross IB, Lawrence P, Oen K. Primary antiphospholipid syndrome with moyamoya-like vascular changes. Pediatr Neurosurg 1999;31:45-8. (Pubitemid 29503051)
121. Schuster JM, Roberts TS. Symptomatic moyamoya disease and aortic coarctation in a patient with Noonan's syndrome: Strategies for management. Pediatr Neurosurg 1999;30:206-10. (Pubitemid 29329865)
122. Rafay MF, Al-Futaisi A, Weiss S, Armstrong D. Hypomelanosis of Ito and Moyamoya disease. J Child Neurol 2005;20:924-6. (Pubitemid 43125273)
123. Qaiser R, Scott RM, Smith ER. Identification of an association between Robinow syndrome and moyamoya. Pediatr Neurosurg 2009;45:69-72.